Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 803

Results For "MP"

10799 News Found

India Health Link join hands with Canopi
Supply Chain | July 16, 2022

India Health Link join hands with Canopi

To strengthen the integrated human-centric preventive health screening ‘Phygital’ ecosystem in India


HEAPS.ai appoints Ritesh Mittal as Head of Strategy and Customer Success for Provider Network
People | July 16, 2022

HEAPS.ai appoints Ritesh Mittal as Head of Strategy and Customer Success for Provider Network

Mittal will be driving expansion of the provider network across India


Enveda appoints Vanitha Sekar as Chief Business Officer
People | July 16, 2022

Enveda appoints Vanitha Sekar as Chief Business Officer

She joins Enveda from Gilead Sciences


Enveric Biosciences advances drug development for mental health indications
Biotech | July 16, 2022

Enveric Biosciences advances drug development for mental health indications

Advancing to IND-enabling studies with multiple drug candidates


Cipla Health signs agreement to acquire Endura Mass
News | July 15, 2022

Cipla Health signs agreement to acquire Endura Mass

This acquisition is in line with Cipla's strategic imperative to augment the company's wellness portfolio for bringing about a shift from an illness to a wellness mindset.


Philips highlights AI-powered precision diagnosis portfolio at ECR 2022
Digitisation | July 15, 2022

Philips highlights AI-powered precision diagnosis portfolio at ECR 2022

Philips demonstrates portfolio of smart connected imaging systems and integrated radiology workflow solutions designed to improve diagnostic confidence and clinical outcomes


Syngene signs 10-year biologics manufacturing agreement with Zoetis
News | July 15, 2022

Syngene signs 10-year biologics manufacturing agreement with Zoetis

Syngene's collaboration with Zoetis started in 2011


Healthcare Triangle closes $6.5 million private placement
News | July 15, 2022

Healthcare Triangle closes $6.5 million private placement

H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.


CEPI funds consortium led by CPI to advance Caltech’s new all-in-one coronavirus vaccine
News | July 15, 2022

CEPI funds consortium led by CPI to advance Caltech’s new all-in-one coronavirus vaccine

Up to $30m funding will be provided to advance an innovative vaccine technology that could protect against current and future SARS-CoV-2 variants and other SARS-like Betacoronaviruses.


USFDA removes Jubilant Generics' Olanzapine, Spironolactone and Valsartan from the excepted products list
Drug Approval | July 14, 2022

USFDA removes Jubilant Generics' Olanzapine, Spironolactone and Valsartan from the excepted products list

Post this currently only Risperidone orally disintegrating tablets are allowed for import into the US from the Roorkee facility.